Effect of lurasidone plus sulpiride on treatment efficacy, psychiatric manifestations, and quality of life among patients with schizophrenia

Table 3 Incidence of adverse events in the two patient groups, n (%)

Indicators	Control group (n = 50)	Observation group (n = 60)	χ²	P value
Fatigue	2 (4.00)	1 (1.67)
Xerostomia	1 (2.00)	1 (1.67)
Insomnia	1 (2.00)	2 (3.33)
Anorexia	1 (2.00)	0 (0.00)
Headache	3 (6.00)	2 (3.33)
Total	8 (16.00)	6 (10.00)	0.884	0.347